In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EnzymeRx LLC

www.enzymerx.com

Latest From EnzymeRx LLC

Deals Shaping The Medical Industry, July/August 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced May and June 2014.

BioPharmaceutical Medical Device

Deals Shaping the Medical Industry (01/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.

Selected Start-Ups (11/2008)

In Vivo briefly describes these recently founded companies: Archer Pharmaceuticals, Arginetix, Carmat, Catena Pharmaceuticals, EnzymeRX, and P&H Therapeutics.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • EnzymeRx LLC
  • Senior Management
  • Tony Fiorino, MD, PhD, Pres. & CEO
    Elliot Maza, CFO
    John Bomalaski, MD, CMO
  • Contact Info
  • EnzymeRx LLC
    Phone: (201) 843-4424
    17 Arcadian Ave., Ste. 104
    Paramus, NJ 07652
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register